Technical Analysis for BAX - Baxter International Inc.

Grade Last Price % Change Price Change
C 41.54 -0.17% -0.07
BAX closed down 0.17 percent on Monday, March 18, 2024, on 71 percent of normal volume.
6 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Down 3 Days in a Row Weakness -0.17%
Down 4 Days in a Row Weakness -0.17%
Down 5 Days in a Row Weakness -0.17%
Gapped Down Weakness -0.17%
Fell Below 20 DMA Bearish -1.14%
MACD Bearish Signal Line Cross Bearish -1.14%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 12 hours ago
Outside Day about 12 hours ago
60 Minute Opening Range Breakout about 13 hours ago
Fell Below Previous Day's Low about 15 hours ago
2x Volume Pace 4 days ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Baxter International Inc. Description

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. Baxter International Inc. was founded in 1931 and is based in Deerfield, Illinois.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: S&P 500 Medicine Infectious Diseases Disorders Kidney Disease Dialysis Medical Research Medical Products Membrane Technology Syringe Nutrition Products End Stage Renal Disease Hemodialysis Immune Disorders Infusion Pump Renal Disease Burns Kidney Stage Renal Disease Hemophilia Nephrology Antitrypsin Deficiency Renal Dialysis Specialty Pharmacy Alpha 1 Antitrypsin Drug Wholesalers Hemophilia A Kidney Dialysis Kidney Failure Compounding Peritoneal Dialysis Biosurgery Products

Is BAX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 49.1206
52 Week Low 30.5482
Average Volume 3,773,058
200-Day Moving Average 39.31
50-Day Moving Average 40.36
20-Day Moving Average 42.16
10-Day Moving Average 42.69
Average True Range 0.93
RSI (14) 50.00
ADX 41.51
+DI 25.09
-DI 19.91
Chandelier Exit (Long, 3 ATRs) 41.20
Chandelier Exit (Short, 3 ATRs) 42.27
Upper Bollinger Bands 43.80
Lower Bollinger Band 40.52
Percent B (%b) 0.31
BandWidth 7.77
MACD Line 0.60
MACD Signal Line 0.81
MACD Histogram -0.2171
Fundamentals Value
Market Cap 21.1 Billion
Num Shares 508 Million
EPS -0.15
Price-to-Earnings (P/E) Ratio -276.93
Price-to-Sales 1.39
Price-to-Book 2.48
PEG Ratio 1.70
Dividend 1.16
Dividend Yield 2.79%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.57
Resistance 3 (R3) 42.58 42.25 42.40
Resistance 2 (R2) 42.25 41.99 42.25 42.34
Resistance 1 (R1) 41.90 41.83 41.73 41.88 42.28
Pivot Point 41.57 41.57 41.49 41.56 41.57
Support 1 (S1) 41.21 41.31 41.05 41.20 40.80
Support 2 (S2) 40.88 41.15 40.88 40.74
Support 3 (S3) 40.53 40.88 40.68
Support 4 (S4) 40.51